Hemostemix is a biotechnology-based clinical-stage company listed on the OTC market with the ticker symbol HMTXF for investor-related activities.

The trading marked an opening at $0.1500 and closed at 0.1443 with a slight downfall of 3.80% in the initial value.



https://hemostemix.com/intellectual-property-...completed/

https://www.otcmarkets.com/stock/HMTXF/news/H...?id=351995

https://www.newsfilecorp.com/redirect/7exnWhZAxj

https://www.newsfilecorp.com/release/120166

https://www.youtube.com/watch?v=s8UUx_mh_E8

https://hemostemix.com/ceo-updates/